Alzheimer’s Disease AD/PD Conference 2017: on the verge of something – Kieger
icon-menu-open Created with Sketch.
icon-menu-close Created with Sketch.
Kieger
icon-arrow Created with Sketch. icon-arrow Created with Sketch.
News
icon-arrow Created with Sketch. icon-arrow Created with Sketch.
Alzheimer's Disease AD/PD Conference 2017: on the verge of something

Alzheimer's Disease AD/PD Conference 2017: on the verge of something

We attended the 13th International Conference on Alzheimer`s & Parkinson’s Diseases in Vienna. Messages we received from the meeting are very encouraging, but patience for new therapies will be needed. Participants felt that we are on the verge of something.

Excitement in the Alzheimer’s Disease (Alzheimer’s) community for Biogen’s aducanumab (anti-abeta antibody) data remains high, as for the first time a disease modifying agent yielded a clinically relevant signal in 2015. The community seems to agree, that the recent failures of Lilly’s solanezumab (another anti-abeta antibody) and Merck’s BACE inhibitor do not question the current understanding of the disease but will help to positively influence future initiatives. Recent research work recognises that Alzheimer’s is a highly heterogenous disease – every patient is different – and that several disease mechanisms are at play.

Related News

Healthcare
4. October 2021

Kieger Impact Healthcare Fund Report

Happy Birthday! Our Kieger Impact Healthcare Fund is turning 1! On this occasion, we are proud to share our Kieger AG Impact Healthcare Report, where we highlight the progress achieved during the past year and reflect on what have been unparalleled times.

Healthcare
1. October 2021

Kieger Healthcare Monthly Commentary

“Sell in May and go away, but remember to come back in September” ... or perhaps October? Most stock markets reached new highs in early September, with economies have seemingly finally put the pandemic behind. At such a "cruising altitude," small turbulences can lead to serious corrections – and the month certainly offered plenty.

Healthcare
24. September 2021

Kieger Healthcare Chart of the Month

What do you think, how many people still take their prescribed drugs after 12? Actually, the numbers are quite scary and vary significantly by the type of the disease. Watch the video to find out more.

Contact

icon-menu-close Created with Sketch.

Get in contact with us by using the form below or via telephone. We look forward to hearing from you.

Something is wrong
Something is wrong
Something is wrong
Something is wrong
Something is wrong
Something is wrong
Something is wrong
Something went wrong. Try again later.

Thank you!

Lorem ipsum dolor sit amet, consectetuer adipiscing elit. Aenean commodo ligula eget dolor. Aenean massa. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Donec quam felis, ultricies nec, pellentesque eu, pretium quis, sem.

Kieger jobs

icon-menu-close Created with Sketch.

There are no job vacancies at the moment.